Simone Wilm
Romanian-Swiss-Cooperation Program: IZERZ0_142226: Integration of medical oncology and palliative care procedures in various institutional and economical settings
Jan 1, 2013Summary of the research plan Background: In the care of advanced incurable cancer patients medical oncologists play a sentinel role in not only providing tumour directed treatment, but also in identifying and treating palliative care needs. In busy o...
Clinical Studies - Jan 1, 2013 - Dec 31, 2015
Completed
Project leader: Strasser Florian
Members: Wilm Simone, Magayakalbermatten N
SMiLE-Lebenssinn, persönliche Werte und Spiritualität bei Patienten mit lebensbedrohlichen Erkrankungen (NFP 67)
Nov 1, 2012Zusammenfassung des Studienprotokolls Principal Investigator : Professor Gian Domenico Borasio, Universitätsspital Lausanne Co-Investigatoren : Mathieu Bernhard, Universitätsspital Lausanne; Dr. Claudia Gamondi Palmesino, Regionalspital Bellinzona...
Clinical Studies - Nov 1, 2012 - Oct 31, 2014
Completed
Project leader: Strasser Florian
Members: Wilm Simone, Magayakalbermatten N
pre-MENAC
Oct 28, 2012
Clinical Studies - Oct 28, 2012 - Sep 26, 2013
Completed
Project leader: Strasser Florian
Members: Wilm Simone, Magayakalbermatten N
Biomarkes Cancer Cachexia in Urin and Blood
Oct 14, 2012Urin
Fundamental Research - Oct 14, 2012 - Dec 15, 2012
Aborted
Project leader: Strasser Florian
Members: Demmer-Steingruber Ruth, Wilm Simone
Decision criteria guiding chemotherapy in palliative intention: prospective study comparing patients, doctors’, and nurses responses- KLS -02785-02-2011
Sep 1, 2012Die Wirksamkeit von Krebstherapien für Patienten mit fortgeschrittenen, unheilbaren Krebserkran-kungen wurde in klinischen Studien untersucht, hauptsächlich bezüglich der Beeinflussung des Tumorwachstums, des Ueberlebens, und der Verträglichkeit der...
Clinical Studies - Sep 1, 2012 - May 31, 2014
Automatically Closed
Project leader: Strasser Florian
Members: Wilm Simone, Magayakalbermatten N
A randomized, double-blind, placebo-controlled multi-center study of BYM338 for treatment of cachexia in patients with stage IV non-small cell lung cancer or stage III/IV adenocarcinoma of the pancreas - EKSG 11/084
Jan 9, 2012Ein ungewollter Gewichtsverlust (Kachexie) ist bei vielen Krebsformen ein unabhängiges Anzeichen für ein kürzeres Gesamtüberleben, selbst vor Beginn einer Chemotherapie. Patienten mit Gewichtsverlust entwickeln zudem häufig stärkere Nebenwirkungen wä...
Clinical Studies - Jan 9, 2012 - Jul 31, 2012
Completed
Project leader: Strasser Florian
Members: Jörger Markus, Gueller Ulrich, Wilm Simone
Development of a module to supplement the EORTC Core instruments for assessment of Health Related Quality of Life in patients with Cancer Cachexia - EKSG 12/091; CTU 12-11
Dec 1, 2011Aims 1. To develop a module to supplement the EORTC QLQ core module, for the assessment of QoL in patients with cancer cachexia. 2. To explore the possible need for parallel development of separate modules for cachexia syndrome, refractory cachexia...
Clinical Studies - Dec 1, 2011 - Dec 31, 2016
Automatically Closed
Project leader: Strasser Florian
Members: Wilm Simone
Systematic Literature Review Population and Outcomes of Clinical Trials in Cachexia
Sep 26, 2011
Clinical Studies - Sep 26, 2011 - Sep 26, 2014
Completed
Project leader: Strasser Florian
Members: Wilm Simone
Current Practices of Parenteral Nutrition in incurable cancer patients, having mild to severe intestinal failure: an international, case-vignette based survey of clinical experts
Sep 1, 2010AIM To collect current practises of parenteral nutrition in patients with advanced incurable cancer with mild to severe intestinal failure by a structured international survey of clinical experts, defined as expectance in advanced cancer care and nut...
Clinical Studies - Sep 1, 2010 - Dec 31, 2013
Completed
Project leader: Strasser Florian
Members: Nestor Karen, Simanek Ralf, Wilm Simone
Effect of lenalidomide (Revlimid) in solid tumour patients with inflammatory cancer cachexia syndrome on lean body mass and muscle strength: A multicenter, proof-of-concept study of fixed dose or CRP-response-guided dose of lenalidomide in relation to new standard basic cachexia management (receiving placebo) EKSG 09/40; CTU-11006
Oct 19, 2009Die Studie zielt darauf ab herauszufinden, ob Lenalidomid (Revlimid®), einmal täglich als Kapsel eingenommen auf nüchternen Magen, eine therapeutische Bedeutung beim tumorbedingten Gewichtsverlust bei Patienten mit entzüdlicher Komponente der Tumorer...
Clinical Studies - Oct 19, 2009 - Jun 30, 2012
Aborted
Project leader: Strasser Florian
Members: Gueller Ulrich, Wilm Simone